Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics

This paper presents sensor nanotechnologies that can be used for the skin-based gas “smelling” of disease. Skin testing may provide rapid and reliable results, using specific “fingerprints” or unique patterns for a variety of diseases and conditions. These can include metabolic diseases, such as dia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anthony Annerino, Pelagia-Irene (Perena) Gouma
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	biomarkers breath skin gas diagnostics monitoring Chemical technology TP1-1185
Acceso en línea:	https://doaj.org/article/4e68eda9246c42b78afc31d9586b3ed9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4e68eda9246c42b78afc31d9586b3ed9
record_format	dspace
spelling	oai:doaj.org-article:4e68eda9246c42b78afc31d9586b3ed92021-11-25T18:57:24ZFuture Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics10.3390/s212275541424-8220https://doaj.org/article/4e68eda9246c42b78afc31d9586b3ed92021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8220/21/22/7554https://doaj.org/toc/1424-8220This paper presents sensor nanotechnologies that can be used for the skin-based gas “smelling” of disease. Skin testing may provide rapid and reliable results, using specific “fingerprints” or unique patterns for a variety of diseases and conditions. These can include metabolic diseases, such as diabetes and cholesterol-induced heart disease; neurological diseases, such as Alzheimer’s and Parkinson’s; quality of life conditions, such as obesity and sleep apnea; pulmonary diseases, such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease; gastrointestinal tract diseases, such as irritable bowel syndrome and colitis; cancers, such as breast, lung, pancreatic, and colon cancers; infectious diseases, such as the flu and COVID-19; as well as diseases commonly found in ICU patients, such as urinary tract infections, pneumonia, and infections of the blood stream. Focusing on the most common gaseous biomarkers in breath and skin, which is nitric oxide and carbon monoxide, and certain abundant volatile organic compounds (acetone, isoprene, ammonia, alcohols, sulfides), it is argued here that effective discrimination between the diseases mentioned above is possible, by capturing the relative sensor output signals from the detection of each of these biomarkers and identifying the distinct breath print for each disease.Anthony AnnerinoPelagia-Irene (Perena) GoumaMDPI AGarticlebiomarkersbreathskin gasdiagnosticsmonitoringChemical technologyTP1-1185ENSensors, Vol 21, Iss 7554, p 7554 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	biomarkers breath skin gas diagnostics monitoring Chemical technology TP1-1185
spellingShingle	biomarkers breath skin gas diagnostics monitoring Chemical technology TP1-1185 Anthony Annerino Pelagia-Irene (Perena) Gouma Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
description	This paper presents sensor nanotechnologies that can be used for the skin-based gas “smelling” of disease. Skin testing may provide rapid and reliable results, using specific “fingerprints” or unique patterns for a variety of diseases and conditions. These can include metabolic diseases, such as diabetes and cholesterol-induced heart disease; neurological diseases, such as Alzheimer’s and Parkinson’s; quality of life conditions, such as obesity and sleep apnea; pulmonary diseases, such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease; gastrointestinal tract diseases, such as irritable bowel syndrome and colitis; cancers, such as breast, lung, pancreatic, and colon cancers; infectious diseases, such as the flu and COVID-19; as well as diseases commonly found in ICU patients, such as urinary tract infections, pneumonia, and infections of the blood stream. Focusing on the most common gaseous biomarkers in breath and skin, which is nitric oxide and carbon monoxide, and certain abundant volatile organic compounds (acetone, isoprene, ammonia, alcohols, sulfides), it is argued here that effective discrimination between the diseases mentioned above is possible, by capturing the relative sensor output signals from the detection of each of these biomarkers and identifying the distinct breath print for each disease.
format	article
author	Anthony Annerino Pelagia-Irene (Perena) Gouma
author_facet	Anthony Annerino Pelagia-Irene (Perena) Gouma
author_sort	Anthony Annerino
title	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
title_short	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
title_full	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
title_fullStr	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
title_full_unstemmed	Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics
title_sort	future trends in semiconducting gas-selective sensing probes for skin diagnostics
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/4e68eda9246c42b78afc31d9586b3ed9
work_keys_str_mv	AT anthonyannerino futuretrendsinsemiconductinggasselectivesensingprobesforskindiagnostics AT pelagiaireneperenagouma futuretrendsinsemiconductinggasselectivesensingprobesforskindiagnostics
_version_	1718410461194485760

Future Trends in Semiconducting Gas-Selective Sensing Probes for Skin Diagnostics

Ejemplares similares